BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 26410754)

  • 1. Preparation of intravenous injection nanoformulation of VESylated gemcitabine by co-assembly with TPGS and its anti-tumor activity in pancreatic tumor-bearing mice.
    Xu Y; Meng H; Du F; Lu W; Liu S; Huang J; Yu J
    Int J Pharm; 2015 Nov; 495(2):792-7. PubMed ID: 26410754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cellular uptake and intracellular drug controlled release of VESylated gemcitabine prodrug nanocapsules.
    Fang Y; Du F; Xu Y; Meng H; Huang J; Zhang X; Lu W; Liu S; Yu J
    Colloids Surf B Biointerfaces; 2015 Apr; 128():357-362. PubMed ID: 25746328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of intravenous injection nanoformulation via co-assemble between cholesterylated gemcitabine and cholesterylated mPEG: enhanced cellular uptake and intracellular drug controlled release.
    Xu Y; Zhong X; Zhang X; Lv W; Yu J; Xiao Y; Liu S; Huang J
    J Microencapsul; 2017 Mar; 34(2):185-194. PubMed ID: 28378597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
    Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
    Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2', 2'-difluorodeoxycytidine with increased solubility, stability, and antitumor activity.
    Valdes SA; Alzhrani RF; Rodriguez A; Lansakara-P DSP; Thakkar SG; Cui Z
    Int J Pharm; 2019 Oct; 570():118609. PubMed ID: 31415878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
    Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
    J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells.
    Suksiriworapong J; Phoca K; Ngamsom S; Sripha K; Moongkarndi P; Junyaprasert VB
    Eur J Pharm Biopharm; 2016 Apr; 101():15-24. PubMed ID: 26802701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles.
    Wang Y; Fan W; Dai X; Katragadda U; Mckinley D; Teng Q; Tan C
    Mol Pharm; 2014 Apr; 11(4):1140-50. PubMed ID: 24579673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
    Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
    J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vivo/in vitro evaluation of formononetin phospholipid/vitamin E TPGS micelles.
    Cheng X; Yan H; Jia X; Zhang Z
    J Drug Target; 2016; 24(2):161-8. PubMed ID: 26325229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
    Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
    Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
    Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy.
    Chen Y; Feng S; Liu W; Yuan Z; Yin P; Gao F
    Mol Pharm; 2017 Apr; 14(4):1190-1203. PubMed ID: 28212490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity.
    Naguib YW; Lansakara-P D; Lashinger LM; Rodriguez BL; Valdes S; Niu M; Aldayel AM; Peng L; Hursting SD; Cui Z
    Neoplasia; 2016 Jan; 18(1):33-48. PubMed ID: 26806350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E (D-alpha-tocopheryl-co-poly(ethylene glycol) 1000 succinate) micelles-superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI.
    Chandrasekharan P; Maity D; Yong CX; Chuang KH; Ding J; Feng SS
    Biomaterials; 2011 Aug; 32(24):5663-72. PubMed ID: 21550654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
    Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
    Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic reduction-sensitive gemcitabine prodrug micelles for near-infrared imaging and pancreatic cancer therapy.
    Han H; Wang H; Chen Y; Li Z; Wang Y; Jin Q; Ji J
    Nanoscale; 2016 Jan; 8(1):283-91. PubMed ID: 26608864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects.
    Mi Y; Zhao J; Feng SS
    Int J Pharm; 2012 Nov; 438(1-2):98-106. PubMed ID: 22954445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.
    Tan X; Fang Y; Ren Y; Li Y; Wu P; Yang X; Liu W
    Int J Nanomedicine; 2019; 14():1255-1268. PubMed ID: 30863058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.